Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$47.09
+$0.45 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$47.30
+$0.21 (+0.45%)
Pre-market:
Sep 22, 2026, 8:48 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 330.56M | 364.23M | 367.02M | 113.3M | 97.82M | 37.18M | 17.49M | 3.88M | -14.23M | -19.8M | -25.09M | -24.43M | -37.77M | -44.66M | -58.57M | -82.62M | -84.53M | -84.86M | -17.91M | -14.51M | -7.73M | -11.49M |
Depreciation & Amortization | 3.25M | 2.41M | 2.42M | 2.42M | 2.43M | 2.43M | 2.23M | 1.92M | 1.6M | 1.28M | 1.24M | 1.23M | 1.18M | 1.12M | 998K | 1.12M | 1.14M | 1.16M | 1.16M | 964K | 868K | 2.64M |
Stock-Based Compensation | 19.87M | 12.84M | 12.71M | 12.05M | 11.33M | 10.58M | 12.39M | 12.24M | 11.54M | 11.18M | 8.81M | 10.95M | 11.72M | 11.94M | 12.39M | 10.64M | 10.14M | 10.05M | 9.49M | 8.78M | 8.46M | 7.91M |
Other Working Capital | -491K | -325K | -7.58M | 1.79M | 6.62M | 1.04M | 14.26M | 3.36M | -1.47M | -4.29M | -1.06M | -3.39M | -3.69M | -4.02M | -5.61M | -576K | 1.46M | -56.89M | 14.05M | 22.16M | 13.08M | 70.21M |
Other Non-Cash Items | -258.03M | -286.96M | -286.98M | -41.22M | -40.85M | -773K | -788K | -826K | -861K | -697K | -213K | 305K | 229K | 50K | 481K | 1.27M | 2.44M | 3.99M | 3.43M | -3.3M | -2.23M | -3.67M |
Deferred Income Tax | 10.36M | 2.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 36K | 36K |
Change in Working Capital | -23.89M | -15.82M | -19.51M | -18.37M | -4.91M | -13.83M | 153K | -6.48M | -10.35M | 1.35M | 9.52M | -9.47M | -8.71M | -20.64M | -29.05M | -1.36M | 2.88M | 69.85M | 9.72M | 17.46M | 800K | -64.47M |
Operating Cash Flow | 82.11M | 79.27M | 75.66M | 68.18M | 65.83M | 35.59M | 31.47M | 10.73M | -12.31M | -6.68M | -5.74M | -21.41M | -33.35M | -52.2M | -73.76M | -70.94M | -67.93M | 196K | 5.88M | 9.39M | 207K | -69.05M |
Capital Expenditures | n/a | n/a | n/a | -26K | -36K | -258K | -396K | -370K | -360K | -138K | -15M | -15.07M | -15.26M | -15.23M | -450K | -356K | -337K | -780K | -627K | -1.15M | -1.18M | -726K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 264K | 264K | 264K | 264K | n/a | n/a | n/a | 195K | 195K |
Purchase of Investments | -145.64M | -155.76M | -153.49M | -132.28M | -80.6M | -49.13M | -35.27M | -30.55M | -37.77M | -39.01M | -31.21M | -21.07M | -30.68M | -22.16M | -29.16M | -50.7M | -77.27M | -144.16M | -141.46M | -135.11M | -110.18M | -72.65M |
Sales Maturities Of Investments | 158.95M | 65.97M | 61.13M | 54.33M | 39.6M | 42.55M | 39.7M | 38.95M | 41.2M | 34.25M | 41.65M | 56.82M | 77.98M | 87.03M | 101.23M | 110.91M | 82.89M | 80M | 62.05M | 58.45M | 97.47M | 103.91M |
Other Investing Acitivies | -70.35M | n/a | n/a | 60K | 98K | 98K | 98K | 136K | 132K | 132K | 259K | 499K | 756K | 1.02M | 893K | 564K | 285K | 21K | 21K | n/a | -195K | -195K |
Investing Cash Flow | -57.03M | -89.79M | -92.37M | -77.92M | -40.94M | -6.74M | 4.13M | 8.17M | 3.2M | -4.76M | -4.3M | 21.18M | 32.8M | 50.93M | 72.78M | 60.67M | 5.82M | -64.94M | -80.04M | -77.81M | -13.89M | 30.54M |
Debt Repayment | -22.75M | -7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.95M | 19.95M | 29.55M | 29.52M | 19.54M | 19.54M | 9.94M | 9.98M | n/a | n/a | n/a | 9.98M |
Common Stock Repurchased | -3.74M | -3.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.06M | -7.5M | -7.02M | 1.95M | -7.89M | -8.65M | -11.64M | -12.62M | -3.65M | -3.27M | -1.58M | -4.17M | -7.39M | -13.24M | -13.59M | -10.41M | -6.05M | 59.4M | 62.68M | 62.26M | 62.04M | 2.82M |
Financial Cash Flow | -33.84M | -10.8M | 601K | 6.64M | -7.48M | -8.65M | -11.64M | -12.62M | -3.65M | -3.27M | 18.37M | 15.79M | 22.17M | 16.88M | 6.55M | 9.73M | 4.49M | 69.38M | 62.68M | 62.26M | 62.04M | 13.33M |
Net Cash Flow | -8.76M | -21.32M | -16.11M | -3.1M | 17.41M | 20.21M | 23.96M | 6.28M | -12.76M | -14.71M | 8.33M | 15.55M | 21.61M | 15.61M | 5.57M | -537K | -57.62M | 4.63M | -11.48M | -6.16M | 48.35M | -25.18M |
Free Cash Flow | 82.11M | 79.27M | 75.66M | 68.14M | 65.79M | 35.33M | 31.08M | 10.36M | -12.67M | -6.82M | -20.74M | -36.49M | -48.62M | -67.42M | -74.21M | -71.29M | -68.27M | -584K | 5.25M | 8.24M | -970K | -69.77M |
Adj. Free Cash Flow | 62.25M | 66.43M | 62.94M | 56.09M | 54.46M | 24.75M | 18.68M | -1.88M | -24.21M | -18M | -29.55M | -47.44M | -60.33M | -79.36M | -86.59M | -81.94M | -78.41M | -10.64M | -4.24M | -539K | -9.43M | -77.69M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.97M | -13.97M | -14.05M | -13.98M | -227.17K | -185.17K | -110K | -182K | 42K | n/a | -195K | -107K |
Growth CapEx | n/a | n/a | n/a | -26K | -36K | -258K | -396K | -370K | -360K | -138K | -1.03M | -1.1M | -1.21M | -1.25M | -222.83K | -170.83K | -227K | -598K | -669K | -1.15M | -982K | -619K |
Owner Earnings | 82.11M | 79.27M | 75.66M | 68.18M | 65.83M | 35.59M | 31.47M | 10.73M | -12.31M | -6.68M | -19.72M | -35.38M | -47.4M | -66.17M | -73.99M | -71.12M | -68.04M | 14K | 5.92M | 9.39M | 12K | -69.15M |
Add to Watchlist
Select watchlists to add or remove RIGL